Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Ophthalmic Disease Therapeutics Market to reach USD 51.81 billion by the end of 2029.

Global Ophthalmic Disease Therapeutics Market Size Study & Forecast, by Drug Class (Anti-inflammatory, Anti-invectives, Anti-VEGF and Others) by Dosage Form (Solid, Liquid and Semisolid), by Disease Indication (Glaucoma, Dry Eye Disease, Retinal Disease, Allergy & Infections and Others), by Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies) and Regional Analysis, 2022-2029

Product Code: HLSDT-72968723
Publish Date: 5-05-2023
Page: 200

Global Ophthalmic Disease Therapeutics Market is valued at approximately USD 31.54 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.4% over the forecast period 2022-2029. Drugs and therapies for treating various ocular ailments such as glaucoma, dry eye disease, retinal diseases, and others are included in ophthalmic disease therapeutics. The Ophthalmic Disease Therapeutics market is expanding because of factors such as the rising prevalence of ophthalmic conditions and increasing clinical trials and pipeline candidates for Innovative Drugs and Therapies.

Globally, the prevalence of ophthalmic diseases such as glaucoma, retinal diseases, dry eye disease, and others is on the rise which is catering for market growth. According to a 2020 article from the American Academy of Ophthalmology (AAO), 3.0 million Americans, of whom 2.7 million are 40 years of age or older, have glaucoma. According to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. The increasing number of initiatives taken by various healthcare organizations, governmental entities, and industry actors, there is a greater awareness among the public about ocular disorders, the market demand for treatments for ocular diseases is anticipated to be boosted by factors such as growing healthcare costs and an increase in the number of ophthalmologists in both developed and developing nations. According to the Welsh Government’s 2021 report, The number of ophthalmic practitioners in Wales climbed to 961 in March 2021 from 885 in March 2020. However, the high cost of Ophthalmic Disease Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Ophthalmic Disease Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the increasing rates of diagnosis and treatment, as well as an increase in the prevalence of numerous ocular illnesses. Additionally, rising healthcare spending in the region supporting eye care and eye health, as well as acceptable compensation for a variety of ocular problems, encourage the region’s major economies to adopt cutting-edge and novel treatments. Whereas Europe is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Viatris Inc.
Novartis AG
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
Regeneron Pharmaceuticals, Inc.
Santen Pharmaceutical Co., Ltd.
Bayer AG
Bausch & Lomb Incorporated
Merck KGaA
Nicox SA

Recent Developments in the Market:
Ø In May 2022, Zhaoke Ophthalmology Limited and Visus Therapeutics, Inc. partnership to commercialize BRIMOCHOL PF and Carbachol PF in Greater China, South Korea, and a few other Southeast Asian countries. Visus Therapeutics, Inc. specializes in the development of ophthalmic therapies. Both of these eye drops lack preservatives and are intended to correct presbyopia-related vision problems.
Ø In March 2022, The European Commission has given Novartis AG clearance to market Beovu, an ophthalmic drug intended to treat diabetic macular edema-related vision loss.

Global Ophthalmic Disease Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Dosage Form, Disease Indication, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Classofferings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
Anti-inflammatory
Anti-invectives
Anti-VEGF
Others

By Dosage Form:
Solid
Liquid
Semisolid
By Disease Indication:
Glaucoma
Dry Eye Disease
Retinal Disease
Allergy & Infections
Others
By Distribution Channel:
Hospital Pharmacies
Retail & Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Ophthalmic Disease Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Ophthalmic Disease Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Ophthalmic Disease Therapeutics Market, by Dosage From, 2019-2029 (USD Billion)
1.2.4. Ophthalmic Disease Therapeutics Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.5. Ophthalmic Disease Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Ophthalmic Disease Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Ophthalmic Disease Therapeutics Market Dynamics
3.1. Ophthalmic Disease Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising Prevalence of Ophthalmic Conditions
3.1.1.2. Increasing Clinical Trials and Pipeline Candidates for Innovative Drugs and Therapies
3.1.2. Market Challenges
3.1.2.1. High Cost of Biologics and Overall Treatment Cost
3.1.3. Market Opportunities
3.1.3.1. Rising Technological Advancements in Drug Delivery Options
3.1.3.2. Rising development of personalised medicine
Chapter 4. Global Ophthalmic Disease Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Ophthalmic Disease Therapeutics Market, by Drug Class
6.1. Market Snapshot
6.2. Global Ophthalmic Disease Therapeutics Market by Drug Class, Performance – Potential Analysis
6.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
6.4.1. Anti-inflammatory
6.4.2. Anti-invectives
6.4.3. Anti-VEGF
6.4.4. Others
Chapter 7. Global Ophthalmic Disease Therapeutics Market, by Dosage From
7.1. Market Snapshot
7.2. Global Ophthalmic Disease Therapeutics Market by Dosage From, Performance – Potential Analysis
7.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Dosage From 2019-2029 (USD Billion)
7.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
7.4.1. Solid
7.4.2. Liquid
7.4.3. Semisolid
Chapter 8. Global Ophthalmic Disease Therapeutics Market, by Disease Indication
8.1. Market Snapshot
8.2. Global Ophthalmic Disease Therapeutics Market by Disease Indication, Performance – Potential Analysis
8.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
8.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
8.4.1. Glaucoma
8.4.2. Dry Eye Disease
8.4.3. Retinal Disease
8.4.4. Allergy & Infections
8.4.5. Others
Chapter 9. Global Ophthalmic Disease Therapeutics Market, by Distribution Channel
9.1. Market Snapshot
9.2. Global Ophthalmic Disease Therapeutics Market by Distribution Channel, Performance – Potential Analysis
9.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
9.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
9.4.1. Hospital Pharmacies
9.4.2. Retail & Online Pharmacies
Chapter 10. Global Ophthalmic Disease Therapeutics Market, Regional Analysis
10.1. Ophthalmic Disease Therapeutics Market, Regional Market Snapshot
10.2. North America Ophthalmic Disease Therapeutics Market
10.2.1. U.S. Ophthalmic Disease Therapeutics Market
10.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
10.2.1.2. Dosage From breakdown estimates & forecasts, 2019-2029
10.2.1.3. Disease Indication breakdown estimates & forecasts, 2019-2029
10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Ophthalmic Disease Therapeutics Market
10.3. Europe Ophthalmic Disease Therapeutics Market Snapshot
10.3.1. U.K. Ophthalmic Disease Therapeutics Market
10.3.2. Germany Ophthalmic Disease Therapeutics Market
10.3.3. France Ophthalmic Disease Therapeutics Market
10.3.4. Spain Ophthalmic Disease Therapeutics Market
10.3.5. Italy Ophthalmic Disease Therapeutics Market
10.3.6. Rest of Europe Ophthalmic Disease Therapeutics Market
10.4. Asia-Pacific Ophthalmic Disease Therapeutics Market Snapshot
10.4.1. China Ophthalmic Disease Therapeutics Market
10.4.2. India Ophthalmic Disease Therapeutics Market
10.4.3. Japan Ophthalmic Disease Therapeutics Market
10.4.4. Australia Ophthalmic Disease Therapeutics Market
10.4.5. South Korea Ophthalmic Disease Therapeutics Market
10.4.6. Rest of Asia Pacific Ophthalmic Disease Therapeutics Market
10.5. Latin America Ophthalmic Disease Therapeutics Market Snapshot
10.5.1. Brazil Ophthalmic Disease Therapeutics Market
10.5.2. Mexico Ophthalmic Disease Therapeutics Market
10.5.3. Rest of Latin America Ophthalmic Disease Therapeutics Market
10.6. Rest of The World Ophthalmic Disease Therapeutics Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Viatris Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Novartis AG
11.2.3. AbbVie Inc.
11.2.4. F. Hoffmann-La Roche Ltd.
11.2.5. Regeneron Pharmaceuticals, Inc.
11.2.6. Santen Pharmaceutical Co., Ltd.
11.2.7. Bayer AG
11.2.8. Bausch & Lomb Incorporated
11.2.9. Merck KGaA
11.2.10. Nicox SA
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now